Your browser doesn't support javascript.
loading
PLA2G6 variants associated with the number of affected alleles in Parkinson's disease in Japan.
Daida, Kensuke; Nishioka, Kenya; Li, Yuanzhe; Yoshino, Hiroyo; Shimada, Tomoyo; Dougu, Nobuhiro; Nakatsuji, Yuji; Ohara, Shinji; Hashimoto, Takao; Okiyama, Ryoichi; Yokochi, Fusako; Suzuki, Chieko; Tomiyama, Masahiko; Kimura, Katsuo; Ueda, Naohisa; Tanaka, Fumiaki; Yamada, Hitoshi; Fujioka, Shinsuke; Tsuboi, Yoshio; Uozumi, Takenori; Takei, Takanobu; Matsuzaki, Shigeru; Shibasaki, Morikazu; Kashihara, Kenichi; Kurisaki, Ryoichi; Yamashita, Tetsuji; Fujita, Nobuya; Hirata, Yoshinori; Ii, Yuichiro; Wada, Chizu; Eura, Nobuyuki; Sugie, Kazuma; Higuchi, Yujiro; Kojima, Fumikazu; Imai, Hisamasa; Noda, Kazuyuki; Shimo, Yasushi; Funayama, Manabu; Hattori, Nobutaka.
Afiliação
  • Daida K; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
  • Nishioka K; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan. Electronic address: nishioka@juntendo.ac.jp.
  • Li Y; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
  • Yoshino H; Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Shimada T; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
  • Dougu N; Department of Neurology, Toyama University Hospital, Toyama, Japan.
  • Nakatsuji Y; Department of Neurology, Toyama University Hospital, Toyama, Japan.
  • Ohara S; Department of Neurology, Iida Hospital, Iida, Nagano, Japan.
  • Hashimoto T; Department of Neurology, Aizawa Hospital, Matsumoto, Japan.
  • Okiyama R; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • Yokochi F; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
  • Suzuki C; Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
  • Tomiyama M; Department of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
  • Kimura K; Department of Neurology, Yokohama City University Medical Center, Yokohama, Japan.
  • Ueda N; Department of Neurology, Yokohama City University Medical Center, Yokohama, Japan.
  • Tanaka F; Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Yamada H; Yokohama Neurology Clinic, Yokohama, Japan.
  • Fujioka S; Department of Neurology, Fukuoka University School of Medicine, Fukuoka, Japan.
  • Tsuboi Y; Department of Neurology, Fukuoka University School of Medicine, Fukuoka, Japan.
  • Uozumi T; Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan.
  • Takei T; Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan.
  • Matsuzaki S; Shiga Prefectural Mental Health Medical Center, Kusatsu, Shiga, Japan.
  • Shibasaki M; Shiga Prefectural Mental Health Medical Center, Kusatsu, Shiga, Japan.
  • Kashihara K; Okayama Neurology Clinic, Okayama, Japan.
  • Kurisaki R; Department of Neurology, National Hospital Organization Kumamoto Saishun Medical Center, Koshi, Kumamoto, Japan.
  • Yamashita T; Department of Neurology, Ariake Seijin Hospital, Kumamoto, Japan.
  • Fujita N; Department of Neurology, Nagaoka Red Cross Hospital, Nagaoka, Niigata, Japan.
  • Hirata Y; Department of Neurology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
  • Ii Y; Department of Neurology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
  • Wada C; Department of Neurology, National Hospital Organization Akita National Hospital, Yurihonjo, Akita, Japan.
  • Eura N; Department of Neurology, Nara Medical University School of Medicine, Kashihara, Nara, Japan.
  • Sugie K; Department of Neurology, Nara Medical University School of Medicine, Kashihara, Nara, Japan.
  • Higuchi Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
  • Kojima F; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
  • Imai H; Department of Neurology, Tokyo Clinic, Tokyo, Japan.
  • Noda K; Department of Neurology, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan.
  • Shimo Y; Department of Neurology, Juntendo University Nerima Hospital, Tokyo, Japan.
  • Funayama M; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan; Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Hattori N; Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan; Research Institute for Diseases of Old Age, Graduate School of Medicine, Juntendo University, Tokyo, Japan. Electronic address: nhattori@juntendo.ac.jp.
Neurobiol Aging ; 97: 147.e1-147.e9, 2021 01.
Article em En | MEDLINE | ID: mdl-32771225
ABSTRACT
This study aimed to evaluate genotype-phenotype correlations of Parkinson's disease (PD) patients with phospholipase A2 group V (PLA2G6) variants. We analyzed the DNA of 798 patients with PD, including 78 PD patients reported previously, and 336 in-house controls. We screened the exons and exon-intron boundaries of PLA2G6 using the Ion Torrent system and Sanger method. We identified 21 patients with 18 rare variants, such that 1, 9, and 11 patients were homozygous, heterozygous, and compound heterozygous, respectively, with respect to PLA2G6 variants. The allele frequency was approximately equal between patients with familial PD and those with sporadic PD. The PLA2G6 variants detected frequently were identified in the early-onset sporadic PD group. Patients who were homozygous for a variant showed more severe symptoms than those who were heterozygous for the variant. The most common variant was p.R635Q in our cohort, which was considered a risk variant for PD. Thus, the variants of PLA2G6 may play a role in familial PD and early-onset sporadic PD.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Variação Genética / Predisposição Genética para Doença / Fosfolipases A2 do Grupo VI / Estudos de Associação Genética / Frequência do Gene Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Variação Genética / Predisposição Genética para Doença / Fosfolipases A2 do Grupo VI / Estudos de Associação Genética / Frequência do Gene Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article